Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Opko Health

http://www.opko.com

Latest From Opko Health

J.P. Morgan Day One: Novartis Reveals Two Deals, Pfizer's Bad Year, Bristol's Wobbly Growth

Daily notebook from the J.P. Morgan Healthcare Conference: Deal and strategy news from Novartis, BMS and Pfizer; Gilead talks lenacapavir PrEP launch plans; BioMarin's new CEO makes an appearance and Saunders explains the status at Bausch + Lomb.

Deals Strategy

Finance Watch: Public Companies Pursue All Options To Fund R&D, Launches

Public Company Edition: Follow-on offerings may not be the favored path to funding development programs or product launches after major milestones in the current environment. Amicus secured $430m in a deal with Blackstone, while OPKO’s Modex garnered up to $168m from BARDA.

Finance Watch Financing

AbbVie To Build On Relationship With Calibr Via Five-Year Extension

Deal Snapshot: Previously partnered on CAR-T therapies for cancer and COVID-19 antivirals, AbbVie and Scripps’ discovery unit Calibr unveil a five-year extension, including new targets and preclinical candidates.

Deals Business Strategies

Regeneron’s CRL For High-Dose Eylea Benefits Roche, Vabysmo

Although the US FDA complete response letter only cites third-party manufacturing issues, analysts say the delayed approval of 8mg Eylea could continue a competitive advantage for Vabysmo into 2024.

Business Strategies Complete Response Letters
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Drug Delivery
    • Generic Drugs
    • Nutraceuticals
    • Vaccines
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Digital Imaging
  • Laboratory Testing Services
    • Anatomical Pathology
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Molecular Diagnostics & Genetic Testing
    • Therapeutic Drug Monitoring
  • Biotechnology
    • Antisense, Oligonucleotides
    • Large Molecule
    • Pharmacogenetics-Pharmacogenomics
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • ALS Distribuidora Limitada
    • Bio-Reference Laboratories, Inc.
    • Claros Diagnostics Inc.
    • CURNA, Inc.
    • Cytochroma, Inc.
    • EirGen Pharma, Ltd.
    • eXegenics, Inc.
    • GeneDX
    • Modigene
    • Inspiro Medical Ltd.
    • OURLab
    • PROLOR Biotech, Inc.
    • Prost-Data, Inc.
    • Silcon Comércio
    • Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos Ltda.
    • Transition Therapeutics Inc.
    • Waratah Pharmaceuticals Inc.
UsernamePublicRestriction

Register